To determine if suppression of Brn-2 leads to reduced invasion of breast cancer cells, we performed Matrigel transwell invasion assays using MDA-MB-231 cells that express BRN2-targeting dicer-substrate siRNA. This evidence concerns the gene POU3F2 and breast cancer.